1. Home
  2. WSFS vs PBLS Comparison

WSFS vs PBLS Comparison

Compare WSFS & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WSFS Financial Corporation

WSFS

WSFS Financial Corporation

HOLD

Current Price

$79.37

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$40.42

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WSFS
PBLS
Founded
1980
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
WSFS
PBLS
Price
$79.37
$40.42
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$76.20
N/A
AVG Volume (30 Days)
290.3K
333.6K
Earning Date
04-23-2026
N/A
Dividend Yield
1.12%
N/A
EPS Growth
15.42
N/A
EPS
3.26
N/A
Revenue
$963,949,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.40
N/A
P/E Ratio
$24.17
N/A
Revenue Growth
50.18
N/A
52 Week Low
$49.92
$25.56
52 Week High
$82.94
$41.49

Technical Indicators

Market Signals
Indicator
WSFS
PBLS
Relative Strength Index (RSI) 47.27 63.79
Support Level $77.08 $37.88
Resistance Level $79.13 $41.49
Average True Range (ATR) 1.40 2.18
MACD -0.31 -0.18
Stochastic Oscillator 42.72 71.48

Price Performance

Historical Comparison
WSFS
PBLS

About WSFS WSFS Financial Corporation

WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: the WSFS Bank segment provides loans and leases, and other financial products to commercial and consumer customers; the Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and the Wealth and Trust segment provides a broad array of planning and advisory services, investment management, trust services, and credit and deposit products to individual, corporate, and institutional clients. The majority of revenue is generated from the WSFS Bank segment.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: